Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Down 0.15%

Collegium Pharmaceutical reported a loss that was worse than expected, leading to a slight decline in stock price. The lack of revenue figures and management commentary leaves investors without additional context for the results. The stock's minor drop reflects cautious sentiment as investors digest the earnings report.